On March 18, Governor Kate Brown appointed members to the Oregon Psilocybin Advisory Board, which held its first meeting on March 31. Since then, the Board has met monthly and created five subcommittees to study facets of the emerging psilocybin industry including research, equity, manufacturing, training, and licensing. I chair the Licensing Subcommittee, which focuses on public health and safety, ethics, and consumer protection. We are developing informed consent documents, professional codes of conduct, and licensing requirements for psilocybin practitioners and facilities.
Each subcommittee reports its findings to the full Advisory Board, which will make regulatory recommendations to the OHA on or before June 30, 2022. After the conclusion of a two-year development phase mandated by Measure 109, the OHA will start accepting license applications from businesses and individuals on January 2, 2023.
Measure 109 requires the OHA to issue licenses for psilocybin manufacturers, testing labs, service centers, and facilitators. With respect to manufacturing, the Board is contemplating a range of psilocybin products that could be produced in Oregon. Its Products Subcommittee, led by Dr. Jessie Uehling, a mycology Professor at Oregon State University, is researching the benefits and drawbacks of various products and manufacturing methods. The group may also